August 23, 2022 Clinical Research/Diagn. Life Science Tools Microscopy Product Launch Roche launches a digital PCR system, a powerful new diagnostics platform in the fight against cancer and other diseases Read more
August 16, 2022 Acad, Gov/Utilities FDA accepts supplemental Biologics License Application for Roche’s Polivy combination for people with previously untreated diffuse large B-cell lymphoma Read more
August 15, 2022 Clinical Research/Diagn. Product Launch Roche launches new diagnostic test for the better understanding of immune response to SARS-CoV-2 Read more
August 12, 2022 Acad, Gov/Utilities Bio/Pharma/CRO Roche announces U.S. FDA approval of Xofluza to treat influenza in children aged five years and older Read more
August 2, 2022 Bio/Pharma/CRO Roche’s subcutaneous formulation of Tecentriq demonstrates positive Phase III results Read more
July 28, 2022 Bio/Pharma/CRO Clinical Research/Diagn. Roche to present scientific progress across Alzheimer’s disease pharmaceutical and diagnostic portfolio at 2022 AAIC Annual Meeting Read more
July 22, 2022 Uncategorized CHMP recommends EU approval of Roche’s Vabysmo, the first bispecific antibody for the eye, for two leading causes of vision loss Read more
July 21, 2022 Uncategorized [Ad hoc announcement pursuant to Art. 53 LR] Roche: Change in the Board of Directors and Corporate Executive Committee in Spring 2023 Read more
July 21, 2022 Uncategorized [Ad hoc announcement pursuant to Art. 53 LR] Roche achieves good results in the first six months of 2022 Read more
July 19, 2022 Acad, Gov/Utilities Roche's Elecsys Amyloid Plasma Panel granted FDA Breakthrough Device Designation to enable a timely diagnosis of Alzheimer’s disease Read more
